You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Influenza

Amantadine, oseltamivir and zanamivir for the treatment of influenza

  • Technology appraisal guidance
  • Reference number: TA168
  • Published:  25 February 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A - provisional matrix of stakeholders

Appendix A - provisional matrix of stakeholders Appendix A - provisional matrix of stakeholders
03 June 2014
(102.96 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 23 July 2014

Back to top